Denoel, Philippe
LondoƱo-Hayes, Patricia
Chlebus, Magda
de Azero, Magdalena Rodriguez
Article History
First Online: 1 June 2018
Competing interests
: The authors declare the following conflicts: P.D. is an employee of the GSK group of companies. P.L.H. is an employee of Sanofi Pasteur. M.C. and M.R.A. are employees of the European Federation of Pharmaceutical Industries and Associations (EFPIA). Functions of the authors in IMI: P.D. is the chair of the Vaccines Europe R&D Working Group, a member of the Infections Control Strategic Governing Group and a member of the BioVacSafe and PERISCOPE projects. P.L.H. is a member of the Vaccines Europe R&D Working Group, a member of the Immunology Strategic Governing Group for Vaccines Europe, leader of the FLUCOP project, EFPIA co-leader of the PERISCOPE project and oversees the IMI Portfolio on Vaccines at Sanofi Pasteur. M.C. is coordinating EFPIA input into IMI strategy development and idea/project generation and is a deputy member of the IMI Governing Board. M.R.A. is coordinating the Vaccines Europe members input to vaccine projects generation.
Free to read: This content has been made available to all.